Wear2B

Noninvasive Blood Glucose Monitoring

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in November 2015 by Ohad Bashan, Wear2B operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters.

Business overview

Wear2B is a Health Tech & Life Sciences company focused on developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters, such as blood glucose levels. The company's core technology leverages artificial intelligence and machine learning within digital healthcare, specifically digital therapeutics, to serve the global market. Wear2B's product is currently in clinical trial, targeting healthcare providers with a B2B2C business model.

Log in to access full profile

Company Intelligence Q&A

When was Wear2B founded?
Wear2B was founded in November 2015.
Who is the founder of Wear2B?
Ohad Bashan is the founder of Wear2B.
What is Wear2B's primary focus?
Wear2B is focused on developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters, such as blood glucose levels.
What is the current product stage of Wear2B?
Wear2B's product is currently in the Clinical Trial stage, indicating it is undergoing testing to evaluate its safety and efficacy before potential market release.
What sector does Wear2B operate in?
Wear2B operates in the Health Tech & Life Sciences sector, specifically within digital health and medical technologies.
Log in to access full profile